Dow Up0.33% Nasdaq Up0.43%

Myriad Genetics Inc. (MYGN)

-NasdaqGS
33.22 Up 0.02(0.06%) 11:19AM EST - Nasdaq Real Time Price
Analyst EstimatesGet Analyst Estimates for:
Earnings EstCurrent Qtr.
Dec 14
Next Qtr.
Mar 15
Current Year
Jun 15
Next Year
Jun 16
Avg. EstimateN/AN/A1.862.20
No. of AnalystsN/AN/A18.0017.00
Low EstimateN/AN/A1.621.82
High EstimateN/AN/A2.002.89
Year Ago EPS0.660.482.261.86
Revenue EstCurrent Qtr.
Dec 14
Next Qtr.
Mar 15
Current Year
Jun 15
Next Year
Jun 16
Avg. Estimate183.56M211.74M797.33M854.68M
No. of Analysts15151917
Low Estimate180.08M183.70M731.60M689.30M
High Estimate187.24M229.20M820.00M998.60M
Year Ago Sales204.06M182.92M778.22M797.33M
Sales Growth (year/est)-10.00%15.80%2.50%7.20%
Earnings HistoryDec 13Mar 14Jun 14Sep 14
EPS Est0.460.460.460.32
EPS Actual0.660.480.440.25
Difference0.200.02-0.02-0.07
Surprise %43.50%4.30%-4.30%-21.90%
EPS TrendsCurrent Qtr.
Dec 14
Next Qtr.
Mar 15
Current Year
Jun 15
Next Year
Jun 16
Current EstimateN/AN/A1.862.20
7 Days Ago0.350.571.862.20
30 Days Ago0.460.531.892.22
60 Days Ago0.470.501.932.22
90 Days Ago0.480.511.942.21
EPS RevisionsCurrent Qtr.
Dec 14
Next Qtr.
Mar 15
Current Year
Jun 15
Next Year
Jun 16
Up Last 7 Days0700
Up Last 30 Days11245
Down Last 30 Days10300
Down Last 90 DaysN/AN/AN/AN/A
Growth EstMYGNIndustrySectorS&P 500
Current Qtr.N/AN/A-72.80%18.70%
Next Qtr.N/AN/A-36.60%18.90%
This Year-17.70%N/A30.90%7.90%
Next Year18.30%N/A21.60%10.70%
Past 5 Years (per annum)11.52%N/AN/AN/A
Next 5 Years (per annum)15.30%14.39%14.40%9.81%
Price/Earnings (avg. for comparison categories)17.85-11.054.8021.09
PEG Ratio (avg. for comparison categories)1.1710.643.743.21
Currency in USD.